Adult Obesity Program to Resume, Health Ministry Confirms

—

in

The Greek Ministry of Health has confirmed that its national adult obesity treatment program will resume as planned. Deputy Health Minister Eirini Agapidaki announced the decision amid concerns from thousands of participants who found themselves abruptly without support after the program—part of the broader national preventive health initiative Pro-lambano (‘I Prevent’) —was paused on 30 June 2026.

A Therapeutic, Not Cosmetic, Approach

Speaking on ACTION 24 television, Agapidaki emphasized that the program is not about weight loss for aesthetic reasons. Instead, it offers a comprehensive, medically supervised therapeutic intervention—including pharmacotherapy, clinical monitoring, and personalized dietary guidance—for adults with both severe obesity (very high BMI) and elevated cardiovascular risk.

“We’re not talking about going to the beach,” she said. “We’re talking about reducing life-threatening cardiovascular risk by treating obesity as a chronic disease.”

High Participation and Technical Resolution

The program currently serves 43,500 beneficiaries. Agapidaki acknowledged a recent technical issue related to European Commission procedures—but clarified that the Commission never questioned either the scientific design of the program or the clinical validity of its pharmacological treatment component. She stressed that Health Minister Adonis Georgiadis and her team have been working intensively to resolve the matter, and that continuity of care remains the top priority.

“I understand how alarming it must feel for someone with severe obesity to fear treatment interruption after making such a serious effort,” she said. “The program will continue. We are finalizing the solution together with the minister—and official announcements will follow shortly.”

Broad Impact of the ‘Pro-lambano’ Initiative

Under the national Pro-lambano program, over 6.5 million citizens have undergone free preventive health screenings. Among them, 300,000 were identified early with significant medical findings—prompting timely follow-up tests and interventions.

Agapidaki cited several success stories: women diagnosed with early-stage breast cancer who received life-saving treatment, and men—whom she specifically noted are often less likely to seek preventive care—who were diagnosed with cardiovascular conditions and underwent immediate angioplasty.